Publications by authors named "Simon Viscogliosi"
Article Synopsis
- The COVERT-MI trial tested high-dose colchicine in patients with acute STEMI and found no reduction in infarct size, while the colchicine group showed an increase in left ventricular thrombus compared to placebo.
- A one-year follow-up revealed no significant differences in major adverse cardiovascular events (MACEs) between the colchicine and placebo groups, with 39.6% of participants experiencing MACEs overall.
- Despite no excess adverse events linked to colchicine, there was a trend toward fewer heart failure events and no notable differences in quality of life scores between the two groups after one year.
